1. Contrast media-induced nephrotoxicity: an overview

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Haemorrhagic complications with thrombolytics

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. H2-antagonist interactions

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Adverse effects of beta agonist asthma therapy

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. Anticonvulsants

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Antidepressants/lithium

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Anti-inflammatories, non-steroidal

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Anti-inflammatories, non-steroidal see Cyclosporin interaction

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Aspirin/ibuprofen/indomethacin

   Newsletter Article 05 February 2013 Pages: 4 - 4

10. Befunolol

    Newsletter Article 05 February 2013 Pages: 4 - 4

11. Benzodiazepine withdrawal

    Newsletter Article 05 February 2013 Pages: 4 - 4

12. Beta agonists

    Newsletter Article 05 February 2013 Pages: 4 - 4

13. Cocaine abuse

    Newsletter Article 05 February 2013 Pages: 4 - 5

14. Contrast media

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Corticosteroids

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Cyclosporin interaction

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Cyclosporin interactions

    Newsletter Article 05 February 2013 Pages: 6 - 6

18. Desoximetasone

    Newsletter Article 05 February 2013 Pages: 6 - 6

19. Diclofenac see Piroxicam

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Gold

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Haloperidol

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Heparin

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Ibuprofen see Aspirin/ibuprofen/indomethacin

    Newsletter Article 05 February 2013 Pages: 6 - 6

24. Indomethacin see Aspirin/ibuprofen/indomethacin

    Newsletter Article 05 February 2013 Pages: 6 - 6

25. Interferon alpha

    Newsletter Article 05 February 2013 Pages: 6 - 7

26. Iopamidol

    Newsletter Article 05 February 2013 Pages: 7 - 7

27. Isotretinoin

    Newsletter Article 05 February 2013 Pages: 7 - 7

28. Lithium see Antidepressants/lithium

    Newsletter Article 05 February 2013 Pages: 7 - 7

29. Mercury poisoning

    Newsletter Article 05 February 2013 Pages: 7 - 7

30. Mesna

    Newsletter Article 05 February 2013 Pages: 7 - 7

31. Methotrexate

    Newsletter Article 05 February 2013 Pages: 7 - 7

32. Minocycline

    Newsletter Article 05 February 2013 Pages: 8 - 8

33. Nifedipine

    Newsletter Article 05 February 2013 Pages: 8 - 8

34. OKT3

    Newsletter Article 05 February 2013 Pages: 8 - 9

35. PCNU

    Newsletter Article 05 February 2013 Pages: 9 - 9

36. Phenylpropanolamine

    Newsletter Article 05 February 2013 Pages: 9 - 9

37. Phenytoin interaction

    Newsletter Article 05 February 2013 Pages: 9 - 9

38. Piroxicam

    Newsletter Article 05 February 2013 Pages: 9 - 10

39. Prednisolone

    Newsletter Article 05 February 2013 Pages: 10 - 10

40. Procainamide

    Newsletter Article 05 February 2013 Pages: 10 - 10

41. Quinine

    Newsletter Article 05 February 2013 Pages: 10 - 10

42. Quinine overdose

    Newsletter Article 05 February 2013 Pages: 10 - 10

43. Ranitidine see Phenytoin interaction

    Newsletter Article 05 February 2013 Pages: 10 - 10

44. Sodium amidotrizoate see Iopamidol

    Newsletter Article 05 February 2013 Pages: 10 - 10

45. Sulfasalazine

    Newsletter Article 05 February 2013 Pages: 10 - 10

46. Suxamethonium

    Newsletter Article 05 February 2013 Pages: 10 - 10

47. Tamoxifen

    Newsletter Article 05 February 2013 Pages: 10 - 11

48. Vaccine, diphtheria, tetanus and pertussis

    Newsletter Article 05 February 2013 Pages: 11 - 11

49. Vancomycin

    Newsletter Article 05 February 2013 Pages: 11 - 12

50. Verapamil

    Newsletter Article 05 February 2013 Pages: 12 - 12